BioAssets
BioAssets Corporation is a 100% Filipino-owned BAI-accredited veterinary diagnostics laboratory serving poultry and swine farmers, veterinarians, and government agencies in the Philippines through PCR, serological, gene sequencing, and microbial testing, supported by the BRIDGES national disease prevention program, BioAssets Academy training, and an online Client Portal.
- Company typePrivate
- Founded2014
- HeadquartersSanto Tomas, Philippines
- Headcount11–50
- GTM typeB2B
- OfferingServices
What BioAssets does
BioAssets Corporation is a 100% Filipino-owned life science company headquartered at the University of the Philippines Los Baños Science Technology Park in Los Baños, Laguna, Philippines. The company operates a Bureau of Animal Industry-accredited Veterinary Diagnostics Laboratory offering nucleic acid detection by PCR, serological tests, microbial isolation and antibiotic sensitivity testing, gene sequencing, necropsy, hematology and biochemistry, mycotoxin testing, and rapid point-of-care diagnostics for key poultry and swine diseases including Newcastle Disease Virus, African Swine Fever Virus, Porcine Circovirus 2, and Avian Influenza. Its core platform includes the BRIDGES Project, a national program combining point-of-need diagnostics, precision diagnostics, and precision medicine through genome sequencing, alongside the BioAssets Academy training program and the BioAssets Livestock Client Portal for online test-result access.
The business operates a B2B sales-led go-to-market model, engaging directly with poultry and swine farmers, veterinary professionals, research institutions, and government agencies across three physical laboratory and office locations in Los Baños, Santo Tomas City (Batangas), and Calasiao (Pangasinan). Revenue is generated primarily through usage-based per-test fees for laboratory diagnostics and distance-based pricing for on-site sample collection services, supplemented by professional services revenue from BioAssets Academy training programs. A freemium Client Portal enables existing customers to access test results digitally, supporting retention and reducing service friction for the SMB livestock farmer customer base.
Founded by a team of scientists, veterinarians, and entrepreneurs, BioAssets positions itself around food security, animal disease prevention, and skills development for the Philippine livestock industry. The company is privately held with no disclosed institutional investors, no public funding rounds, and no disclosed revenue, indicating an early-stage commercial profile with regulatory-validated technical credibility but limited financial transparency.
BioAssets firmographics
Firmographics- Name
- BioAssets
- Legal name
- BioAssets Corporation
- Website
- https://bioassets.com.ph
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioAssets Corporation is a 100% Filipino-owned BAI-accredited veterinary diagnostics laboratory serving poultry and swine farmers, veterinarians, and government agencies in the Philippines through PCR, serological, gene sequencing, and microbial testing, supported by the BRIDGES national disease prevention program, BioAssets Academy training, and an online Client Portal.
- Ownership category
- akta.pro rank
BioAssets industry classification
Industry- Product category
- Veterinary Diagnostics Services
- NAICS
- Veterinary Services (54194), Veterinary Services (541940), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC)
- akta.pro secondary industries
- Food Animal & Herd Health Diagnostics (Surveillance, Production Medicine Lab Testing) (HLAMADAL), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Veterinary Diagnostic Laboratories & Pathology (AFAEANAF), Veterinary Public Health Laboratories (Reference & Confirmatory) (HLAMAJAH), Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation) (AFACADAF)
Keywords
Where BioAssets is headquartered
LocationHeadquarters
- HQ city
- Santo Tomas
- HQ country
- Philippines
- HQ region
- Asia
Offices3 records
Markets served
BioAssets business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Diagnostic Testing Services: Laboratory diagnostic testing services for poultry and swine diseases including PCR, serological tests, microbial methods, necropsy, hematology, and specialty tests. Revenue is generated through per-test fees and sample processing charges. Minimum batch requirements apply for certain tests.
- Sample Collection Services: On-site sample collection services for livestock health testing. Pricing varies based on farm distance.
- Professional Services and Training: BioAssets Academy provides training and skills development for veterinary diagnostics, microbiology, science and technology research for students and professionals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Diagnostic Testing Services |
| Unit Pricing | Pay-as-you-go | Sample Collection |
| Freemium | Monthly | Client Portal Access |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
BioAssets product offering
Product offeringCore offering
BioAssets Corporation operates a Bureau of Animal Industry (BAI)-accredited veterinary diagnostics laboratory in the Philippines that delivers molecular and serological testing, microbial analysis, gene sequencing, necropsy, hematology, and specialty testing for poultry and swine diseases. Diagnostic services are complemented by the BRIDGES Project (point-of-need and precision diagnostics/medicine), BioAssets Academy training programs, and an online Client Portal that gives livestock owners direct access to test results.
Product overview
BioAssets is a life-science company offering a unified platform of veterinary diagnostics services focused on the animal industry in the Philippines. The core offering consists of the BAI-accredited Veterinary Diagnostics Laboratory, which provides nucleic acid detection by PCR, serological tests, microbial methods, gene sequencing, necropsy, rapid tests, hematology/biochemistry, specialty tests, mycotoxin testing, and sample collection services. These diagnostics are supported by the BRIDGES Project, which establishes point-of-need diagnostics, precision diagnostics, and precision medicine capabilities including genome sequencing. BioAssets Academy provides skills development and professional training, while the Client Portal enables livestock owners to access test results online.
Differentiator
Problem solved
Functional benefit
Brands
- BRIDGES Project: Brisk Response to In-location Diagnostics and Genome Sequencing - A Comprehensive and Unified National Program on Animal Disease Prevention and Control covering Point-of-Need Diagnostics, Precision Diagnostics, and Precision Medicine.
- BioAssets Academy
- BioAssets Livestock Client Portal
Products and services
- Veterinary Diagnostics Laboratory BAI-accredited laboratory conducting testing for key diseases in swine and poultry, offering nucleic acid detection, serological tests, microbial methods, and specialty tests for livestock farmers, veterinarians, and government agencies.
- Nucleic Acid Detection by PCR
Companies that use BioAssets
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
BioAssets technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioAssets partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Bureau of Animal Industry (BAI)coreBioAssets Veterinary Diagnostics Laboratory is accredited by the Bureau of Animal Industry to conduct testing for key diseases in swine and poultry. BAI is the government regulatory agency overseeing animal health and disease control programs in the Philippines.
- Farmers (livestock industry stakeholders)coreBioAssets actively engages with farmers as part of its comprehensive approach to animal disease prevention and control. Farmers are direct customers who benefit from point-of-need diagnostics and laboratory services.
- Veterinary professionalscoreVeterinary professionals collaborate with BioAssets for diagnostic support, research collaboration, and implementation of the BRIDGES project for disease control programs.
- Research institutionscoreBioAssets partners with research institutions to foster innovation, knowledge exchange, and shared expertise in animal health and biotechnology.
- Government agenciescoreGovernment agencies collaborate with BioAssets on national disease control programs and the BRIDGES project for comprehensive animal disease prevention and control.
Scale indicators1 record
Recent moves6 records
Expansion highlights6 records
BioAssets competitors and assessment
Company assessmentBroad incumbents
- Antech Diagnostics (Mars Petcare): Large veterinary reference-laboratory network offering PCR, serology and pathology, comparable in service model though focused on larger developed markets.
- Zoetis: Major animal-health company with diagnostics, vaccines and reference labs for livestock, spanning the disease-prevention space BioAssets operates in.
- IDEXX Laboratories: Global leader in veterinary diagnostics and reference laboratory services; overlaps with BioAssets' lab testing but as part of a far broader companion- and livestock-animal portfolio.
- Heska: Provides veterinary diagnostic testing and lab instruments, overlapping with BioAssets' diagnostic services albeit with a companion-animal and instrument emphasis.
- Neogen: Offers animal-health diagnostics and food/feed safety testing including mycotoxin analysis, overlapping with BioAssets' pathogen and mycotoxin testing lines.
Regional players
- MEDION: Indonesian animal-health company with poultry diagnostics and disease-monitoring services, operating in the same Southeast Asian livestock market segment.
- Royal GD (GD Animal Health): Netherlands-based animal-health lab running herd-health surveillance and diagnostics for poultry and swine, a close functional analog serving a different geography.
Direct peers
- IDvet (Innovative Diagnostics): Develops veterinary diagnostic assays for poultry and swine pathogens, overlapping directly with BioAssets' infectious-disease testing niche.
- BioChek: Specializes in serology and PCR diagnostics for poultry and swine diseases, closely mirroring BioAssets' core disease panel and livestock focus.
Others
- Thermo Fisher Scientific (Applied Biosystems veterinary PCR): Supplies PCR reagents, sequencing and diagnostic platforms used in veterinary labs; an enabling technology provider rather than a direct competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
BioAssets social profiles
Digital presenceBioAssets compliance and trust
Trust signalCompliance1 record
BioAssets financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioAssets leadership team
Management profileNumber of profiles
BioAssets funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioAssets M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioAssets
What does BioAssets do?
BioAssets Corporation operates a Bureau of Animal Industry (BAI)-accredited veterinary diagnostics laboratory in the Philippines that delivers molecular and serological testing, microbial analysis, gene sequencing, necropsy, hematology, and specialty testing for poultry and swine diseases. Diagnostic services are complemented by the BRIDGES Project (point-of-need and precision diagnostics/medicine), BioAssets Academy training programs, and an online Client Portal that gives livestock owners direct access to test results.
Is BioAssets a public or private company?
BioAssets is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioAssets founded?
BioAssets was founded in 2014. It employs 11 to 50 people.
Where is BioAssets based?
BioAssets is headquartered in Santo Tomas, Philippines, in the Asia region.
How does BioAssets make money?
Three revenue lines are on record. Veterinary Diagnostic Testing Services are the primary driver. The others are sample Collection Services and professional Services and Training.
Who are BioAssets's main competitors?
Broad incumbents on record are Antech Diagnostics (Mars Petcare), Zoetis, IDEXX Laboratories, Heska and Neogen. Regional players are MEDION and Royal GD (GD Animal Health). Direct peers are IDvet (Innovative Diagnostics) and BioChek. Thermo Fisher Scientific (Applied Biosystems veterinary PCR) is listed as an others.
Does BioAssets have an API?
No public API is recorded for BioAssets.
What industry is BioAssets in?
BioAssets's product category is Veterinary Diagnostics Services. Its primary akta.pro industry code is HLAMADAC, Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology), with a secondary code of HLAMADAL, Food Animal & Herd Health Diagnostics (Surveillance, Production Medicine Lab Testing). Its NAICS code is 54194 and its SIC code is 8071.